Members |
acceptabilityId |
von Willebrand disease, type IID (disorder) |
Preferred (foundation metadata concept) |
von Willebrand disease, type IIE |
Preferred (foundation metadata concept) |
von Willebrand disease, type IIE (disorder) |
Preferred (foundation metadata concept) |
von Willebrand disease, type IIF |
Preferred (foundation metadata concept) |
von Willebrand disease, type IIF (disorder) |
Preferred (foundation metadata concept) |
von Willebrand disease, type IIG |
Preferred (foundation metadata concept) |
von Willebrand disease, type IIG (disorder) |
Preferred (foundation metadata concept) |
von Willebrand disease, type IIH |
Preferred (foundation metadata concept) |
von Willebrand disease, type IIH (disorder) |
Preferred (foundation metadata concept) |
von Willebrand disease, type IS/III |
Preferred (foundation metadata concept) |
von Willebrand disease, type IS/III (disorder) |
Preferred (foundation metadata concept) |
von Willebrand disorder |
Preferred (foundation metadata concept) |
von Willebrand disorder (disorder) |
Preferred (foundation metadata concept) |
von Willebrand factor |
Preferred (foundation metadata concept) |
von Willebrand factor (substance) |
Preferred (foundation metadata concept) |
von Willebrand factor activity |
Preferred (foundation metadata concept) |
von Willebrand factor activity |
Preferred (foundation metadata concept) |
von Willebrand factor activity (procedure) |
Preferred (foundation metadata concept) |
von Willebrand factor activity (procedure) |
Preferred (foundation metadata concept) |
von Willebrand factor antibody |
Preferred (foundation metadata concept) |
von Willebrand factor antibody (substance) |
Preferred (foundation metadata concept) |
von Willebrand factor antigen |
Preferred (foundation metadata concept) |
von Willebrand factor antigen |
Preferred (foundation metadata concept) |
von Willebrand factor antigen (VWF:Ag) level |
Acceptable (foundation metadata concept) |
von Willebrand factor antigen (substance) |
Preferred (foundation metadata concept) |
von Willebrand factor antigen (substance) |
Preferred (foundation metadata concept) |
von Willebrand factor antigen level |
Preferred (foundation metadata concept) |
von Willebrand factor antigen level (procedure) |
Preferred (foundation metadata concept) |
von Willebrand factor antigen level measurement |
Acceptable (foundation metadata concept) |
von Willebrand factor collagen binding assay |
Preferred (foundation metadata concept) |
von Willebrand factor collagen binding assay (procedure) |
Preferred (foundation metadata concept) |
von Willebrand factor inhibitor |
Acceptable (foundation metadata concept) |
von Willebrand factor inhibitor disorder |
Preferred (foundation metadata concept) |
von Willebrand factor inhibitor disorder (disorder) |
Preferred (foundation metadata concept) |
von Willebrand factor level |
Preferred (foundation metadata concept) |
von Willebrand factor level |
Preferred (foundation metadata concept) |
von Willebrand factor level (procedure) |
Preferred (foundation metadata concept) |
von Willebrand factor level (procedure) |
Preferred (foundation metadata concept) |
von Willebrand factor multimer |
Preferred (foundation metadata concept) |
von Willebrand factor multimer (substance) |
Preferred (foundation metadata concept) |
von Willebrand factor multimer assay |
Preferred (foundation metadata concept) |
von Willebrand factor multimer assay (procedure) |
Preferred (foundation metadata concept) |
von Willebrand factor multimeric analysis |
Preferred (foundation metadata concept) |
von Willebrand factor multimeric analysis (procedure) |
Preferred (foundation metadata concept) |
von Willebrand factor only product |
Preferred (foundation metadata concept) |
von Willebrand factor only product in parenteral dose form |
Preferred (foundation metadata concept) |
von Willebrand factor products allergy |
Preferred (foundation metadata concept) |
von Willebrand factor products allergy (disorder) |
Preferred (foundation metadata concept) |
von Willebrand factor ristocetin cofactor |
Preferred (foundation metadata concept) |
von Willebrand factor ristocetin cofactor |
Acceptable (foundation metadata concept) |
von Willebrand factor ristocetin cofactor (substance) |
Preferred (foundation metadata concept) |
von Willebrand factor-containing product |
Preferred (foundation metadata concept) |
von Willebrand factor-containing product in parenteral dose form |
Preferred (foundation metadata concept) |
von Willebrand receptor |
Preferred (foundation metadata concept) |
von Willebrand receptor (substance) |
Preferred (foundation metadata concept) |
von Willebrand screening test |
Preferred (foundation metadata concept) |
von Willebrand screening test (procedure) |
Preferred (foundation metadata concept) |
von Willebrand's disease |
Acceptable (foundation metadata concept) |
von Willebrand's disease |
Preferred (foundation metadata concept) |
von Willebrand's disease (disorder) |
Preferred (foundation metadata concept) |
von Willebrand-Jurgens disease |
Acceptable (foundation metadata concept) |
von Willebrand-Jürgens disease |
Acceptable (foundation metadata concept) |
w |
Preferred (foundation metadata concept) |
w-Amidase |
Preferred (foundation metadata concept) |
w-Amidase (substance) |
Preferred (foundation metadata concept) |
w-Hydroxydecanoate dehydrogenase |
Preferred (foundation metadata concept) |
w-Hydroxydecanoate dehydrogenase (substance) |
Preferred (foundation metadata concept) |
w-Protein |
Acceptable (foundation metadata concept) |
w-hydroxylase |
Acceptable (foundation metadata concept) |
w/v |
Preferred (foundation metadata concept) |
w/w |
Preferred (foundation metadata concept) |
w1 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
w10 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
w11 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
w12 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
w13 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
w14 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
w15 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
w16 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
w17 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
w18 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
w19 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
w2 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
w20 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
w21 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
w3 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
w4 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
w5 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
w6 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
w7 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
w8 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
w9 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
watt |
Preferred (foundation metadata concept) |
watt (qualifier value) |
Preferred (foundation metadata concept) |
watt/centimetre squared |
Acceptable (foundation metadata concept) |
weber |
Preferred (foundation metadata concept) |
weber (qualifier value) |
Preferred (foundation metadata concept) |
week |
Preferred (foundation metadata concept) |
week (qualifier value) |
Preferred (foundation metadata concept) |
weeks |
Acceptable (foundation metadata concept) |
weeks per month |
Acceptable (foundation metadata concept) |